Literature DB >> 22457280

Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.

Federico Simonetta1, Camille Lecuroux, Isabelle Girault, Cécile Goujard, Martine Sinet, Olivier Lambotte, Alain Venet, Christine Bourgeois.   

Abstract

Regulatory T-cell (Treg) quantification in human immunodeficiency virus (HIV) infection remains ill defined because of the lack of reliable specific markers to identify human Tregs and the diversity of clinical stages of HIV infection. Using a recently described Treg identification strategy based on CD45RA and Foxp3 expression, we performed an extensive quantification of total, naive (CD45RA(+)Foxp3(low)), and effector (CD45RA(-)Foxp3(high)) Tregs in different contexts of HIV infection: primary HIV infection, long-term viremic patients, aviremic patients treated with highly active antiretroviral therapy, and HIV controllers. We showed that although total Treg percentages were mildly affected by HIV infection, Treg absolute numbers were significantly reduced in all groups studied. We demonstrated that although naive Treg numbers were essentially preserved, effector Tregs were consistently affected during HIV infection. Finally, we demonstrated that effector but not total or naive Treg numbers were negatively correlated with the magnitude of HIV-specific CD8 T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457280      PMCID: PMC3989210          DOI: 10.1093/infdis/jis235

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Depletion of regulatory T cells in HIV infection is associated with immune activation.

Authors:  Mark P Eggena; Banson Barugahare; Norman Jones; Martin Okello; Steven Mutalya; Cissy Kityo; Peter Mugyenyi; Huyen Cao
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

2.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

Authors:  Jan Andersson; Adriano Boasso; Jakob Nilsson; Rui Zhang; Norah J Shire; Stefan Lindback; Gene M Shearer; Claire A Chougnet
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

4.  Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

Authors:  Laurence Weiss; Vladimira Donkova-Petrini; Laure Caccavelli; Michèle Balbo; Cédric Carbonneil; Yves Levy
Journal:  Blood       Date:  2004-07-22       Impact factor: 22.113

5.  Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.

Authors:  Einar M Aandahl; Jakob Michaëlsson; Walter J Moretto; Frederick M Hecht; Douglas F Nixon
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

7.  The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection.

Authors:  Allan R Tenorio; Jeffrey Martinson; David Pollard; Linda Baum; Alan Landay
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

8.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

9.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  28 in total

1.  Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.

Authors:  Tianyu He; Egidio Brocca-Cofano; Delbert G Gillespie; Cuiling Xu; Jennifer L Stock; Dongzhu Ma; Benjamin B Policicchio; Kevin D Raehtz; Charles R Rinaldo; Cristian Apetrei; Edwin K Jackson; Bernard J C Macatangay; Ivona Pandrea
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

3.  Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV.

Authors:  G Degaffe; R Zakhour; W Zhang; G A Contreras; C S Bell; G Rodriguez; G Del Bianco; N Pérez; L J Benjamins; J R Murphy; G P Heresi; D Q Tran
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

4.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

5.  Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency.

Authors:  Megan A O'Connor; Jennifer L Vella; William R Green
Journal:  J Gen Virol       Date:  2015-08-06       Impact factor: 3.891

Review 6.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities.

Authors:  Netanya G Sandler; Daniel C Douek
Journal:  Nat Rev Microbiol       Date:  2012-08-13       Impact factor: 60.633

Review 7.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

8.  Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.

Authors:  Marco A Lorio; Rossana Rosa; Jose F Suarez; Phillip Ruiz; Gaetano Ciancio; George W Burke; Jose F Camargo
Journal:  Transpl Immunol       Date:  2016-06-11       Impact factor: 1.708

Review 9.  Role of regulatory T cells during virus infection.

Authors:  Tamara Veiga-Parga; Sharvan Sehrawat; Barry T Rouse
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

10.  CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.

Authors:  Mkunde Chachage; Georgios Pollakis; Edmund Osei Kuffour; Kerstin Haase; Asli Bauer; Yuka Nadai; Lilli Podola; Petra Clowes; Matthias Schiemann; Lynette Henkel; Dieter Hoffmann; Sarah Joseph; Sabin Bhuju; Leonard Maboko; Fred Stephen Sarfo; Kirsten Eberhardt; Michael Hoelscher; Torsten Feldt; Elmar Saathoff; Christof Geldmacher
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.